Endeavour and Baird Capital led a $46m Series C round in Virtual Incision.

Endeavour, a venture capital and growth equity firm, and Baird Capital, a venture capital, growth equity and private equity investments firm, led a $46m Series C round in Virtual Incision, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery with participation from Bluestem Capital and others. “We are thrilled to have Endeavour Vision and Baird lead this round of financing at this important stage of our company’s growth, along with the continued strong support of our largest shareholder, Bluestem. Virtual Incision’s goal is to transform surgery by providing a practical and hassle-free platform that will enable efficient, effective, and affordable access to robotic-assisted technology, regardless of the site of care. We are excited that this funding will support our efforts to advance MIRA, so that more patients can ultimately experience the benefits of minimally invasive surgery,” John Murphy, Virtual Incision President and CEO.